• Je něco špatně v tomto záznamu ?

Five-Year Outcomes: Laparoscopic Greater Curvature Plication for Treatment of Morbid Obesity

K. Doležalova-Kormanova, JN. Buchwald, D. Skochova, D. Pichlerova, TW. McGlennon, M. Fried,

. 2017 ; 27 (11) : 2818-2828.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18024977
E-zdroje Online Plný text

NLK ProQuest Central od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2010-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-02-01 do Před 1 rokem
Public Health Database (ProQuest) od 1997-02-01 do Před 1 rokem

BACKGROUND: Laparoscopic greater curvature plication (LGCP) is a newer metabolic/bariatric surgical procedure that requires no resection, bypass, or implantable device. We report outcomes in a cohort of LGCP patients at 5-year follow-up. METHODS: Body mass index (BMI, kg/m2) evolution, excess weight loss (%EWL), excess BMI loss (%EBMIL), and total weight loss (%TWL) were recorded. Repeated measures analysis of variance (ANOVA) was used to assess BMI change over 5 years. Two-step cluster analysis was used to profile LGCP patients according to significant characteristics relative to successful 5-year weight loss. RESULTS: Of patients entering the study between 2010 and 2011 with complete weight data through 5-year follow-up (86.9%, 212/244), mean age was 45.8 ± 10.9 years; mean baseline BMI, 41.4 ± 5.5 (81.6% women); 58 patients (27.4%) had type 2 diabetes. Mean operative time was 69.0 min; mean hospitalization, 38 h (24-72). ANOVA indicated a significant BMI reduction out to 2 years (p < 0.001), a plateau at 3 and 4 years, and a moderate but significant BMI increase at 5 years (p < 0.01). EBMIL at 1, 2, 3, 4, and 5 years was as follows: 50.7 ± 9.1%, 61.5 ± 8.1%, 60.2 ± 7.0%, 58.5 ± 7.0%, and 56.8 ± 6.3%. At 5 years, 79.2% (168/212) of patients were successful; 20.8% (44/212) experienced a suboptimal weight outcome; mean weight regain, 9.2%. Cluster analysis identified four distinct LGCP patient profiles. Diabetes improvement rate was 65.5%. There were 12 reoperations (4.9%): 4 emergency (1.6%) and 8 (3.3%) elective. There was no mortality. CONCLUSIONS: At 5-year follow-up, LGCP proved to be safe and effective, with 56.8% EBMIL and a low rate of complications.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024977
003      
CZ-PrNML
005      
20180718103603.0
007      
ta
008      
180709s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11695-017-2709-3 $2 doi
035    __
$a (PubMed)28560523
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Doležalova-Kormanova, K $u First Faculty of Medicine, Charles University, Prague, Czech Republic. karinkorm@seznam.cz. OB Klinika a.s, Pod Krejcarkem 975, 130 00, Prague 3, Czech Republic. karinkorm@seznam.cz.
245    10
$a Five-Year Outcomes: Laparoscopic Greater Curvature Plication for Treatment of Morbid Obesity / $c K. Doležalova-Kormanova, JN. Buchwald, D. Skochova, D. Pichlerova, TW. McGlennon, M. Fried,
520    9_
$a BACKGROUND: Laparoscopic greater curvature plication (LGCP) is a newer metabolic/bariatric surgical procedure that requires no resection, bypass, or implantable device. We report outcomes in a cohort of LGCP patients at 5-year follow-up. METHODS: Body mass index (BMI, kg/m2) evolution, excess weight loss (%EWL), excess BMI loss (%EBMIL), and total weight loss (%TWL) were recorded. Repeated measures analysis of variance (ANOVA) was used to assess BMI change over 5 years. Two-step cluster analysis was used to profile LGCP patients according to significant characteristics relative to successful 5-year weight loss. RESULTS: Of patients entering the study between 2010 and 2011 with complete weight data through 5-year follow-up (86.9%, 212/244), mean age was 45.8 ± 10.9 years; mean baseline BMI, 41.4 ± 5.5 (81.6% women); 58 patients (27.4%) had type 2 diabetes. Mean operative time was 69.0 min; mean hospitalization, 38 h (24-72). ANOVA indicated a significant BMI reduction out to 2 years (p < 0.001), a plateau at 3 and 4 years, and a moderate but significant BMI increase at 5 years (p < 0.01). EBMIL at 1, 2, 3, 4, and 5 years was as follows: 50.7 ± 9.1%, 61.5 ± 8.1%, 60.2 ± 7.0%, 58.5 ± 7.0%, and 56.8 ± 6.3%. At 5 years, 79.2% (168/212) of patients were successful; 20.8% (44/212) experienced a suboptimal weight outcome; mean weight regain, 9.2%. Cluster analysis identified four distinct LGCP patient profiles. Diabetes improvement rate was 65.5%. There were 12 reoperations (4.9%): 4 emergency (1.6%) and 8 (3.3%) elective. There was no mortality. CONCLUSIONS: At 5-year follow-up, LGCP proved to be safe and effective, with 56.8% EBMIL and a low rate of complications.
650    _2
$a dospělí $7 D000328
650    _2
$a bariatrická chirurgie $x škodlivé účinky $x metody $x statistika a číselné údaje $7 D050110
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a diabetes mellitus 2. typu $x epidemiologie $x chirurgie $7 D003924
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a gastrektomie $x metody $7 D005743
650    _2
$a lidé $7 D006801
650    _2
$a laparoskopie $x škodlivé účinky $x metody $x statistika a číselné údaje $7 D010535
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a morbidní obezita $x epidemiologie $x chirurgie $7 D009767
650    _2
$a délka operace $7 D061646
650    _2
$a pooperační komplikace $x epidemiologie $x etiologie $7 D011183
650    _2
$a reoperace $x statistika a číselné údaje $7 D012086
650    _2
$a výsledek terapie $7 D016896
650    _2
$a hmotnostní úbytek $7 D015431
655    _2
$a časopisecké články $7 D016428
700    1_
$a Buchwald, J N $u Division of Scientific Research Writing, Medwrite Medical Communications, Maiden Rock, WI, USA.
700    1_
$a Skochova, D $u General University Hospital, Prague, and Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
700    1_
$a Pichlerova, D $u OB Klinika a.s, Pod Krejcarkem 975, 130 00, Prague 3, Czech Republic.
700    1_
$a McGlennon, T W $u Statistical Analysis and Quality of Life Assessment, McGlennon MotiMetrics, Maiden Rock, WI, USA.
700    1_
$a Fried, M $u First Faculty of Medicine, Charles University, Prague, Czech Republic. OB Klinika a.s, Pod Krejcarkem 975, 130 00, Prague 3, Czech Republic.
773    0_
$w MED00180469 $t Obesity surgery $x 1708-0428 $g Roč. 27, č. 11 (2017), s. 2818-2828
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28560523 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180718103903 $b ABA008
999    __
$a ok $b bmc $g 1317108 $s 1021898
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 27 $c 11 $d 2818-2828 $i 1708-0428 $m Obesity surgery $n Obes Surg $x MED00180469
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace